We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ginkgo Bioworks (NYSE: DNA) today confirmed that it has collected, identified, and sequenced three samples containing the novel BA.3 sublineage of the Omicron variant.
Olive Labs announced their partnership with Concentric by Ginkgo to provide a scalable, accessible, and simple testing modality for COVID-19 - pooled testing - to serve schools operating hybrid or in-person learning.